Quinolone-indolone conjugate induces apoptosis by inhibiting the EGFR-STAT3-HK2 pathway in human cancer cells

Liu,Ying‑Hua; Wei,Xiao-Li; Hu,Guo‑Qiang; Wang,Tian‑Xiao

doi:10.3892/mmr.2015.3716

Quinolone-indolone conjugate induces apoptosis by inhibiting the EGFR-STAT3-HK2 pathway in human cancer cells

Authors:
- Ying‑Hua Liu
- Xiao-Li Wei
- Guo‑Qiang Hu
- Tian‑Xiao Wang
View Affiliations

Affiliations: Biopharmaceutical Department, Institute of Traditional Chinese Medicine, College of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China
Published online on: May 4, 2015 https://doi.org/10.3892/mmr.2015.3716
Pages: 2749-2756

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The epidermal growth factor receptor (EGFR) is involved in the proliferation of human tumors and is an effective target for the treatment of cancer. In the present study, a novel quinolone‑indolone conjugate, QIC1 [9‑Fluoro‑3,7‑dihydro‑3‑methyl‑10‑ (4‑methyl ‑1‑piperazinyl) ‑6‑(2‑oxo‑1,2‑dihydro‑indol‑3‑ylidenemethyl) ‑7‑oxo‑2H‑(1,4) oxazino(2,3,4‑ij)quinoline], which targeted EGFR, was synthesized in order to investigate the anticancer activity and the potential mechanisms underlying the effect of this compound in human cancer cells. Using MTT assays it was observed that QIC1 inhibited the growth of HepG2 human hepatoma cells, MCF7 human breast cancer cells, HeLa human cervical cancer cells and A549 human lung adenocarcinoma cells. QIC1 arrested cell cycle progression at the G2/M phase in HepG2 cells. QIC1 inhibited the synthesis of DNA in A549 cells. In addition, it resulted in cell apoptosis, in association with increased expression of Bax and reduced expression of Bcl‑2. Further analyses demonstrated that QIC1 attenuated the activity of EGFR, and the downstream signal transducer and activator of transcription 3 (STAT3)‑mediated hexokinase II (HK2) signaling pathways. Furthermore, QIC1 exhibited antiproliferative effects in MCF7/DOX human doxorubicin‑resistant breast cancer cells and also enhanced the anticancer activity of doxorubicin in these cells. In conclusion, the inhibition of proliferation and the induction of apoptosis was associated with reduced expression of phospho‑EGFR‑phospho‑STAT3‑HK2. The present results suggest a potential role for QIC1 in the treatment of human cancer.

View Figures

View References

1	Shehata MA and Karim NA: Influenza vaccination in cancer patients undergoing systemic therapy. Clin Med Insights Oncol. 8:57–64. 2014.PubMed/NCBI
2	Lo HW, Hsu SC and Hung MC: EGFR signaling pathway in breast cancers: From traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat. 95:211–218. 2006. View Article : Google Scholar
3	Ribeiro FA, Noguti J, Oshima CT and Ribeiro DA: Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: A promising approach. Anticancer Res. 34:1547–1552. 2014.PubMed/NCBI
4	Zahonero C and Sánchez-Gómez P: EGFR-dependent mechanisms in glioblastoma: Towards a better therapeutic strategy. Cell Mol Life Sci. 71:3465–3488. 2014. View Article : Google Scholar : PubMed/NCBI
5	Arfaoui A, Kriaa L, Znaidi N, Gritli S, Bouacha H, Zermani R and Rammeh S: Over-expression of EGFR is closely correlated to poor prognosis in Tunisian patients with non-small cell lung adenocarcinoma. J Immunoassay Immunochem. 35:256–268. 2014. View Article : Google Scholar : PubMed/NCBI
6	Su JC, Lin KL, Chien CM, Chuang PW, Chang LS and Lin SR: Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells. Clin Exp Pharmacol Physiol. 37:833–840. 2010.PubMed/NCBI
7	Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, et al: Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. Br J Pharmacol. 170:807–821. 2013. View Article : Google Scholar : PubMed/NCBI
8	Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, et al: Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One. 8:e628232013. View Article : Google Scholar : PubMed/NCBI
9	Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, et al: Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int J Oncol. 31:129–136. 2007.PubMed/NCBI
10	Zhang X, Yue P, Page BD, Li T, Zhao W, et al: Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci USA. 109:9623–9628. 2012. View Article : Google Scholar : PubMed/NCBI
11	Kortylewski M and Yu H: Stat3 as a potential target for cancer immunotherapy. J Immunother. 30:131–139. 2007. View Article : Google Scholar : PubMed/NCBI
12	Tai WT, Cheng AL, Shiau CW, Huang HP, Huang JW, et al: Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. J Hepatol. 55:1041–1048. 2011. View Article : Google Scholar : PubMed/NCBI
13	Warburg O: On the origin of cancer cells. Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
14	Koppenol WH, Bounds PL and Dang CV: Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 11:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
15	Hernández JF, Urueña CP, Cifuentes MC, Sandoval TA, Pombo LM, Castañeda D, Asea A and Fiorentino S: A Petiveria alliacea standardized fraction induces breast adenocarcinoma cell death by modulating glycolytic metabolism. J Ethnopharmacol. 153:641–649. 2014. View Article : Google Scholar : PubMed/NCBI
16	Chen WL, Wang JH, Zhao AH, Xu X, Wang YH, et al: A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood. 124:1645–1654. 2014. View Article : Google Scholar : PubMed/NCBI
17	Venmar KT, Kimmel DW, Cliffel DE and Fingleton B: IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth. Biochim Biophys Acta. 1853:1219–1228. 2015. View Article : Google Scholar : PubMed/NCBI
18	Chen J, Zhang S, Li Y, Tang Z and Kong W: Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumour Biol. 35:3743–3753. 2014. View Article : Google Scholar
19	Wang TX, Liu YH and Shi XY: Oridonin induces apoptosis of HepG2 cells via downregulating STAT3-HK II pathway. Chinese Pharmacological Bulletin. 30:397–402. 2014.In Chinese.
20	Li J, Liu T, Zhao L, Chen W, Hou H, et al: Ginsenoside 20(S)-Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells. Int J Oncol. 2:775–781. 2015.
21	Li Z, Li X, Wu S, Xue M and Chen W: Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci. 105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
22	Moiseeva EP, Heukers R and Manson MM: EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis. 28:435–445. 2007. View Article : Google Scholar
23	Chen J, Wang W, Wang H, Liu X and Guo X: Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis. Drug Discov Ther. 8:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
24	Yamaguchi H and Wang HG: The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene. 20:7779–7786. 2001. View Article : Google Scholar : PubMed/NCBI
25	Le Gall M, Chambard JC, Breittmayer JP, Grall D, Pouysségur J and Van Obberghan Schilling E: The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell. 11:1103–1112. 2000. View Article : Google Scholar : PubMed/NCBI
26	Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, et al: Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest. 102:1385–1392. 1998. View Article : Google Scholar : PubMed/NCBI
27	Tai WT, Cheng AL, Shiau CW, Liu CY, Ko CH, et al: Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3. Mol Cancer Ther. 11:452–463. 2012. View Article : Google Scholar
28	Wicke L, Engels JW, Gambari R and Saab AM: Synthesis and antiproliferative activity of quinolone nucleosides against the human myelogenous leukemia k-562 cell line. Arch Pharm (Weinheim). 346:757–765. 2013. View Article : Google Scholar
29	Shou KJ, Li J, Jin Y and Lv YW: Design, synthesis, biological evaluation, and molecular docking studies of quinolone derivatives as potential antitumor topoisomerase I inhibitors. Chem Pharm Bull (Tokyo). 61:631–636. 2013. View Article : Google Scholar
30	Bargou RC, Wagener C, Bommert K, Mapara MY, Daniel PT, et al: Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest. 97:2651–2659. 1996. View Article : Google Scholar : PubMed/NCBI
31	Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, et al: Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer. 60:854–859. 1995. View Article : Google Scholar : PubMed/NCBI
32	Blando JM, Carbajal S, Abel E, Beltran L, Conti C, et al: Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice. Neoplasia. 13:254–265. 2011. View Article : Google Scholar : PubMed/NCBI
33	Lin J, Tang H, Jin X, Jia G and Hsieh JT: p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Oncogene. 21:3082–3088. 2002. View Article : Google Scholar : PubMed/NCBI
34	Vangala Jr, Dudem S, Jain N and Kalivendi SV: Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): Potential role in bortezomib-mediated anticancer therapy. J Biol Chem. 289:12612–12622. 2014. View Article : Google Scholar : PubMed/NCBI
35	Wu K, Chang Q, Lu Y, Qiu P, Chen B, et al: Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells. Oncotarget. 4:2430–2438. 2013.PubMed/NCBI